SCHEMBL6312570

SCHEMBL6312570

O=C(O)C(=O)Nc1sc(CNS(=O)(=O)c2ccc(Cl)cc2)cc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.43
METAP2 P50579 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
MAPT P10636 2/20 0.40
CYP2C19 P33261 2/20 0.40
GAA P10253 1/20 0.40
TUBB P07437 1/20 0.40
CYP2C9 P11712 1/20 0.40
HTT P42858 1/20 0.40
ACLY P53396 1/20 0.39
ALDH1A1 P00352 1/20 0.39
WDR5 P61964 1/20 0.39
MCL1 Q07820 1/20 0.39
CCR2 P41597 1/20 0.39
LMNA P02545 1/20 0.39
PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318973 0.90 ALDH1A1 (0.44) METAP2MEN1KMT2AHTTACLY
SCHEMBL6312060 0.89 CYP19A1 (0.43) CYP19A1METAP2MEN1KMT2AMAPT
SCHEMBL6317838 0.89 CYP19A1 (0.43) CYP19A1METAP2MEN1KMT2ACYP1A2
SCHEMBL6312441 0.87 MAPT (0.47) METAP2CYP3A4MAPTCYP2C19ALDH1A1
SCHEMBL6313473 0.86 POLB (0.50) MEN1KMT2AMAPTHTTALDH1A1
SCHEMBL6316710 0.84 NAMPT (0.43) MAPT
SCHEMBL6311869 0.79 ALDH1A1 (0.44) MEN1KMT2ACYP1A2CYP3A4MAPT
SCHEMBL6318375 0.79 MEN1 (0.49) MEN1KMT2AMAPTGAAHTT
SCHEMBL6311647 0.78 ALDH1A1 (0.43) MEN1KMT2ACYP1A2CYP3A4MAPT
SCHEMBL6318139 0.77 PTPN1 (0.42) MEN1KMT2AMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2005-06-02 US claimed
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2002-11-07 US claimed
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-03 US claimed
EP-1062204-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP claimed
WO-1999046244-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO claimed
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2005-06-02 US disclosed
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2002-11-07 US disclosed
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-03 US disclosed
EP-1062204-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046244-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRO CYP19A1 453/4885METAP2 228/4885MEN1 3299/4885
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) PTPRCAP, PTPRS, PTPRA CYP19A1 454/4885METAP2 221/4885MEN1 3307/4885
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPN1 CYP19A1 158/4885METAP2 476/4885MEN1 4004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.